Molecular-Driven Therapy in Advanced Thyroid Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Current Treatment Options in Oncology"
DOI: 10.1007/s11864-021-00822-7
Abstract: With a growing understanding of the biologic drivers of different thyroid cancers, there is an ongoing revolution in the treatment of aggressive and advanced disease variants. This includes matching patients with specific point mutations or… read more here.
Keywords: thyroid cancer; molecular driven; therapy advanced; driven therapy ... See more keywords
Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?
Sign Up to like & getrecommendations! Published in 2017 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2017.1356714
Abstract: ABSTRACT Introduction: Recent genetic and molecular discoveries regarding alterations in diffuse large B-cell lymphoma (DLBCL) deeply changed the approach to this lymphoproliferative disorder. Novel additional predictors of outcomes and new therapeutic strategies are being introduced… read more here.
Keywords: cell; molecular driven; large cell; diffuse large ... See more keywords
From hyperplasia to carcinoma: a molecular driven adrenal disease.
Sign Up to like & getrecommendations! Published in 2025 at "European journal of endocrinology"
DOI: 10.1093/ejendo/lvaf105
Abstract: Bilateral Macronodular Adrenocortical Disease (BMAD) is characterized by bilateral benign macronodules and, frequently, autonomous cortisol secretion. Germline molecular alterations of tumor suppressor genes are identified in around 30% of cases, the most frequent being ARMC5.… read more here.
Keywords: carcinoma molecular; disease; carcinoma; molecular driven ... See more keywords